Globe Life Inc. is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company demonstrates steady financial growth and positive analyst sentiment, the technical indicators suggest a neutral to slightly bearish short-term trend. Additionally, hedge fund selling and lack of strong trading signals further support a hold recommendation.
The MACD is negatively expanding (-0.172), indicating bearish momentum. RSI is neutral at 41.064, and the stock is trading below the pivot level of 144.125. However, moving averages are bullish (SMA_5 > SMA_20 > SMA_200), suggesting long-term strength.

Analysts have raised price targets consistently, with JPMorgan setting a high target of $
The company forecasts a 5.9% sales growth rate for 2026 and a 5% EPS growth.
Dividend growth of 22.2% reflects strong financial health.
Hedge funds are selling heavily, with a 1440.51% increase in selling activity.
The MACD and RSI suggest no strong bullish momentum in the short term.
Market sentiment is neutral to slightly bearish, with SP500 down 0.56%.
In Q4 2025, revenue increased by 3.64% YoY to $1.52 billion, net income rose by 4.27% YoY to $266 million, and EPS grew by 9.30% YoY to $3.29, indicating steady financial growth.
Analysts are generally positive on Globe Life, with multiple firms raising price targets recently. JPMorgan has the highest target at $181, while TD Cowen considers it a top pick in U.S. life insurance for 2026.